Patents by Inventor Jason M. Shohet

Jason M. Shohet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MicroRNA-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
    Patent number: 8765707
    Abstract: The present invention provides a method of improving a therapeutic response to a cancer treatment, in a subject, the method comprising administering an effective amount of an agent that enhances the expression of microRNA-140-5p or an agent that mimics the effects of microRNA-140-5p. Further provided is a method of treating a cancer in a subject in need of such treatment comprising the step of administering an effective amount of a microRNA-140-5p or an agent that enhances the expression of microRNA-140-5p.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: July 1, 2014
    Assignees: University of Houston System, Baylor College of Medicine
    Inventors: Preethi H. Gunaratne, Jason M. Shohet
  • MicroRNA-140-5P as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
    Publication number: 20120269883
    Abstract: The present invention provides a method of improving a therapeutic response to a cancer treatment, in a subject, the method comprising administering an effective amount of an agent that enhances the expression of microRNA-140-5p or an agent that mimics the effects of microRNA-140-5p. Further provided is a method of treating a cancer in a subject in need of such treatment comprising the step of administering an effective amount of a microRNA-140-5p or an agent that enhances the expression of microRNA-140-5p.
    Type: Application
    Filed: April 23, 2012
    Publication date: October 25, 2012
    Inventors: Preethi H. Gunaratne, Jason M. Shohet
  • Genes regulated by MYCN activation
    Publication number: 20030119009
    Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed by MYCN activation and which may be used in their entirety or in part to diagnose, to stage, to treat, or to monitor the treatment of a subject with neuroblastoma.
    Type: Application
    Filed: February 25, 2002
    Publication date: June 26, 2003
    Inventors: Susan G. Stuart, Jed G. Nuchtern, Sharon E. Plon, Jason M. Shohet